Yuming Jiang | AI in Healthcare | Best Researcher Award

Posted on by sciencefather

Assist. Prof. Dr. Yuming Jiang | AI in Healthcare | Best Researcher Award

Assistant Professor of Radiation Oncology at Wake Forest University School of Medicine, United States

Dr. Yuming Jiang, MD, PhD, is an Assistant Professor in the Department of Radiation Oncology at Wake Forest University School of Medicine, North Carolina, USA. His research and clinical expertise focus on the integration of artificial intelligence and digital pathology to improve cancer prognosis and treatment strategies. With a strong background in oncology and computational medicine, Dr. Jiang has made significant contributions to the understanding of tumor microenvironments and the application of deep learning in radiomics.

Profile

Google Scholar

Education

Dr. Jiang obtained his MD and PhD degrees from prestigious institutions, demonstrating a commitment to both clinical practice and scientific research. He completed his PhD in oncology at a leading university in China, followed by a postdoctoral fellowship at Stanford University from 2018 to 2023. In August 2023, he joined Wake Forest University School of Medicine as an Assistant Professor, where he continues to advance the field of radiation oncology through innovative research and patient-centered care.

Experience

Dr. Jiang has a diverse professional background that spans clinical medicine, academic research, and technological innovation. Before joining Wake Forest University, he worked as a Postdoctoral Research Fellow at Stanford University, where he contributed to groundbreaking studies on digital pathology, cancer immunotherapy, and noninvasive imaging techniques. His expertise in artificial intelligence and machine learning has enabled him to develop predictive models for cancer prognosis, treatment response, and survival outcomes.

Research Interests

Dr. Jiang’s research is centered on the intersection of oncology and artificial intelligence. His key interests include deep learning-based radiomics, tumor microenvironment analysis, and predictive modeling for personalized cancer treatment. He aims to harness computational tools to enhance diagnostic accuracy and therapeutic decision-making in radiation oncology. His work has had a profound impact on the understanding of tumor biology and has paved the way for more effective, individualized treatment strategies.

Awards

Dr. Jiang has been recognized for his contributions to oncology and medical research with several prestigious awards. His research has received accolades from leading medical societies and journals, highlighting his role in advancing cancer diagnostics and treatment methodologies. His innovative work in AI-driven oncology has earned him invitations to speak at international conferences and collaborate with esteemed institutions worldwide.

Publications

Jiang Y, Zhang Z, Wang W, Huang W, et al. “Biology-guided deep learning predicts prognosis and cancer immunotherapy response.” Nature Communications, 2023; 14: 5135. (Cited by 16.6)

Jiang Y, Zhou K, Sun Z, Wang H, et al. “Non-invasive tumor microenvironment evaluation using deep learning radiomics.” Cell Reports Medicine, 2023; 4:101146. (Cited by 14.3)

Jiang Y, Zhang Z, Yuan Q, Wang W, et al. “Predicting peritoneal recurrence from CT images using multi-task deep learning.” Lancet Digital Health, 2022; 4(5): e340-e350. (Cited by 36.6)

Jiang Y, Li R, Li G. “Artificial intelligence for clinical oncology: current status and future outlook.” Science Bulletin, 2023; (23): 00113-5. (Cited by 18.9)

Jiang Y, Liang X, Wang W, Chen C, et al. “Radiographical assessment of tumor stroma and treatment outcomes using deep learning.” Lancet Digital Health, 2021; 3(6): e371-e382. (Cited by 36.6)

Jiang Y, Jin C, Yu H, Wu J, et al. “Deep Learning CT Signature to Predict Survival and Chemotherapy Benefit in Gastric Cancer.” Annals of Surgery, 2021; 274(6): e1153-e1161. (Cited by 13.8)

Jiang Y, Wang H, Wu J, Chen C, et al. “Noninvasive imaging evaluation of tumor immune microenvironment in gastric cancer.” Annals of Oncology, 2020; 31(6): 760-768. (Cited by 32.9)

Conclusion

Dr. Yuming Jiang is at the forefront of integrating artificial intelligence into oncology, bringing innovative solutions to cancer diagnosis and treatment. His expertise in deep learning, radiomics, and tumor microenvironment studies has significantly advanced the field of radiation oncology. With a strong research background and a commitment to improving patient outcomes, Dr. Jiang continues to contribute to the medical community through his pioneering work in AI-driven cancer diagnostics and therapy.

Peng YU | AI in Healthcare | Best Researcher Award

Posted on by sciencefather

Mr. Peng YU | AI in Healthcare | Best Researcher Award

Associate Senior Doctor at The Second Affiliated Hospital of Nanchang University, China

Dr. Peng Yu is an Associate Senior Doctor in the Department of Endocrinology & Metabolism at The Second Affiliated Hospital of Nanchang University. With a strong background in medicine and extensive experience in both clinical and academic settings, he has made significant contributions to the study of endocrinology, metabolism, and cardiovascular diseases. His research spans various areas, including diabetes, cardiovascular health, and molecular mechanisms of metabolic disorders. In addition to his role as a clinician, he is an active researcher, reviewer for several prestigious international journals, and a recipient of multiple awards recognizing his contributions to medical science.

Profile

Scopus

Education

Dr. Yu earned his Ph.D. in Medicine from Nanchang University in 2017 and previously obtained a Master’s degree in Medicine from Nanjing Medical University in 2014. His academic journey has provided him with in-depth expertise in internal medicine, cardiology, and metabolic disorders. Furthering his research career, he completed a fellowship at Massachusetts General Hospital, Harvard Medical School, focusing on cutting-edge research in CCP medicine. His multidisciplinary education has allowed him to integrate clinical expertise with molecular and cellular research, contributing to advancements in the field of endocrinology and metabolism.

Experience

Dr. Yu has held various roles in the medical field, beginning as a Resident Doctor at The Second Affiliated Hospital of Nanchang University from 2017 to 2019. He was later promoted to Attending Doctor, serving from 2019 to 2021. Since 2021, he has been an Associate Senior Doctor at the same institution, where he continues to provide expert medical care, mentor students, and engage in research activities. His collaborations with prominent researchers, including those at Harvard Medical School and Jilin University, have enriched his expertise and research output. His involvement in over 60 research projects, including several funded by the National Natural Science Foundation of China, highlights his leadership in medical research.

Research Interests

Dr. Yu’s research primarily focuses on endocrinology and metabolism, with particular emphasis on diabetes, cardiovascular diseases, and the molecular mechanisms underlying metabolic disorders. His expertise extends to mitochondrial function, oxidative stress, and the role of programmed cell death in disease progression. Utilizing various research methodologies, including confocal microscopy, Seahorse metabolic analysis, and in vivo disease modeling, he has contributed to the understanding of metabolic disorders at both cellular and systemic levels. His work also explores novel therapeutic targets for diabetic cardiomyopathy and myocardial ischemia-reperfusion injury, positioning him at the forefront of translational medicine in this domain.

Awards

Dr. Yu has been recognized for his contributions to medical research with multiple awards, including:

  • Jiangxi Provincial Science and Technology Progress Third Prize (2019)
  • The Third Prize of Medical Science and Technology of Jiangsu Province (2019, 2023)
  • Young Innovative Talent Award, The Second Affiliated Hospital of Nanchang University (2023)

His achievements underscore his commitment to advancing medical knowledge and improving clinical outcomes in endocrinology and metabolism.

Publications

Dr. Yu has published extensively, with over 150 academic papers, including more than 100 SCI-indexed publications. His recent notable works include:

Yu P et al. “Comprehensive exploration of programmed cell death landscape in lung adenocarcinoma combining multi-omic analysis and experimental verification.” Sci Rep. 2025; 15(1):5364.

Yu P et al. “Performance of ChatGPT on the Chinese Postgraduate Examination for Clinical Medicine: Survey Study.” JMIR Med Educ. 2024; 10:e48514.

Zhao H, Li X, Yu P et al. “Association between weight loss and outcomes in patients undergoing atrial fibrillation ablation: A systematic review and meta-analysis.” Nutr Metab (Lond). 2023; 20(1):5.

Yu P et al. “Obesity and clinical outcomes in COVID-19 patients without comorbidities.” Front Endocrinol. 2022; 13:936976.

Yu P et al. “Dexmedetomidine post-conditioning alleviates myocardial ischemia-reperfusion injury in rats by ferroptosis inhibition via SLC7A11/GPX4 axis activation.” Hum Cell. 2022; 35(3):836-848.

Peng Y et al. “The Association of Serum IL-10 Levels with the Disease Activity in Systemic-Onset Juvenile Idiopathic Arthritis Patients.” Mediators Inflamm. 2021; 2021:6650928.

Conclusion

Dr. Peng Yu is a distinguished clinician and researcher specializing in endocrinology and metabolism. His contributions to the field through extensive research, innovative approaches to disease treatment, and active mentorship have positioned him as a leading expert in his domain. With numerous research grants, impactful publications, and prestigious awards, he continues to drive advancements in medical science. His work not only enhances the understanding of metabolic disorders but also informs the development of novel therapeutic strategies, ensuring better patient outcomes in the future.

Yuriy Gusev | AI in Healthcare | Best Use of Data in Healthcare Award

Posted on by sciencefather

Assoc. Prof. Dr. Yuriy Gusev | AI in Healthcare | Best Use of Data in Healthcare Award

Director of Health Informatics and Data Science Program at Georgetown University, United States

Yuriy Gusev is an esteemed Associate Professor of Bioinformatics at Georgetown University Medical Center’s Innovation Center for Biomedical Informatics (ICBI) and Department of Oncology. He is recognized for his extensive expertise in computational biology, bioinformatics, and systems biology, with a particular focus on cancer research. Dr. Gusev has dedicated his career to bioinformatics, computational modeling, and the development of innovative bioinformatics tools and methodologies. He also plays a leading role in the Health Informatics and Data Science graduate program, and co-directs the Biostatistics and Bioinformatics Shared Resource at the Lombardi Cancer Center. Throughout his career, Dr. Gusev has contributed significantly to multi-institutional cancer research efforts, particularly through large-scale studies, including the Georgetown Database of Cancer (G-DOC), and various NIH-funded programs.

Profile

Scopus

Education

Dr. Gusev’s academic journey began with a Master of Science in Applied Mathematics from State University of St. Petersburg in Russia. He later earned his Ph.D. in Computational Biology from the Central Research Institute of Roentgenology & Radiology in St. Petersburg, Russia. Dr. Gusev further honed his expertise with a postdoctoral position at the Waksman Institute, Rutgers University, where he focused on Computational Modeling in Cancer Research. These experiences laid the foundation for his innovative approach to bioinformatics and cancer research.

Experience

Dr. Gusev’s professional journey spans over three decades, with pivotal positions at several renowned institutions. After his postdoctoral work at Rutgers, he held various roles, including faculty research associate at Johns Hopkins University, senior research scientist at Molecular Staging Inc., and assistant professor at the University of Oklahoma Health Sciences Center. In 2009, he joined Georgetown University as an Associate Professor. Alongside his academic appointments, Dr. Gusev has directed numerous research projects and collaborated extensively in multi-disciplinary research programs across cancer genomics, bioinformatics, and computational biology.

Research Interests

Dr. Gusev’s research interests lie at the intersection of computational biology, bioinformatics, and cancer research. His primary focus includes the study of tumor heterogeneity, chromosomal instability, microRNA, and long-noncoding RNA regulation in cancer. He is particularly invested in the application of computational models and bioinformatics methods to analyze large-scale genomic and transcriptomic data. Dr. Gusev is also passionate about integrating molecular, imaging, and clinical data to advance personalized medicine and precision oncology. His work involves high-throughput data analysis, machine learning techniques for biomarker discovery, and the development of cloud-based platforms to streamline cancer research workflows.

Awards

Dr. Gusev has been recognized with numerous accolades throughout his career. Notable awards include the Charles and Johanna Bush Postdoctoral Fellowship, NSF travel awards for his work in tumor heterogeneity and mathematical population dynamics, and the Executive Leadership Award from the Mid-South Computational Biology and Bioinformatics Society. His contributions to computational cancer research were further acknowledged with the 2008 Executive Leadership Award, and his research impact continues to be recognized by various scientific bodies.

Publications

Dr. Gusev has authored or co-authored numerous influential publications. His research in tumor heterogeneity, chromosomal instability, and microRNA profiling has resulted in multiple highly cited papers. Some key publications include:

Axelrod DE, Gusev Y, Kuczek T. “Persistence of cell cycle times over many generations as determined by heritability of colony sizes of ras oncogene-transformed and non-transformed cells.” Cell Proliferation, 1993, 26(3), 235-249.

Gusev Y, Kagansky V, Dooley WC. “Long-term dynamics of chromosomal instability in cancer: a transition probability model.” Mathematical and Computer Modelling, 2001, 33(12), 1253-1273.

Gusev Y, Bhuvaneshwar K, Song L, Zenklusen JC, Fine H, Madhavan S. “The REMBRANDT study, a large collection of genomic data from brain cancer patients.” Nature Scientific Data, 2018; 5:180158.

Bhuvaneshwar K, Belouali A, Singh V, et al. “G-DOC Plus – an integrative bioinformatics platform for precision medicine.” BMC Bioinformatics, 2016; 17(1):193.

Lei Song, Krithika Bhuvaneshwar, Yue Wang, et al. “CINdex: a bioconductor package for analysis of chromosome instability in DNA copy number data.” Cancer Informatics, 2017, Volume 16, PMID: 29343938.

His works have been cited extensively, contributing to advances in cancer bioinformatics, precision oncology, and the study of molecular biomarkers in cancer.

Conclusion

Dr. Yuriy Gusev has made significant contributions to the field of computational biology and bioinformatics, particularly in cancer research. His work has greatly advanced the understanding of tumor heterogeneity, chromosomal instability, and non-coding RNA regulation in cancer. As an educator, researcher, and leader, he continues to influence the development of bioinformatics tools and platforms that facilitate precision medicine. Dr. Gusev’s expertise in computational modeling, genomic data analysis, and multi-omics integration positions him as a pivotal figure in cancer research and bioinformatics. His ongoing efforts to apply innovative computational approaches to clinical oncology will undoubtedly lead to further breakthroughs in cancer treatment and personalized therapies.

Javad Amini Mahabadi | AI in Healthcare | Best Researcher Award

Posted on by sciencefather

Dr. Javad Amini Mahabadi | AI in Healthcare | Best Researcher Award

Ph.D. in Reproductive Biology | Kashan University of Medical Sciences, Kashan | Iran

Dr. Javad Amini Mahabadi is a distinguished researcher in reproductive biology and stem cell research. He holds a Ph.D. in Reproductive Biology from Kashan University of Medical Sciences, where he has been actively contributing to the advancement of medical sciences. With a deep commitment to academic excellence, Dr. Amini Mahabadi has played a pivotal role in various research initiatives focusing on IVF, histopathology, and medical genetics. His expertise extends to scientific writing, laboratory techniques, and mentoring young researchers. As a multilingual scholar fluent in Persian and English, he engages in numerous academic workshops and research committees, striving to bridge the gap between theoretical knowledge and clinical application.

Profile

Orcid

Education

Dr. Javad Amini Mahabadi pursued his academic journey at Kashan University of Medical Sciences, where he obtained his Ph.D. in Reproductive Biology. His educational background is strongly rooted in cellular biology, stem cell differentiation, and infertility treatment methodologies. His research focus during his doctoral studies revolved around innovative applications of stem cell technology in germ cell differentiation, leading to groundbreaking findings in reproductive health. His academic training has provided him with an extensive knowledge base in histopathology, embryology, and medical genetics, making him a valuable asset to the scientific community.

Experience

Dr. Amini Mahabadi boasts over a decade of experience in academia and research. He has been an integral part of the Gametogenesis Research Center at Kashan University of Medical Sciences, where he has actively contributed to various projects on stem cell applications, male infertility, and regenerative medicine. He has served as a mentor and research guide to graduate students, overseeing numerous dissertations and research endeavors. His involvement in high-impact research collaborations with esteemed institutions and journals has significantly enriched his professional expertise. As a reviewer for reputable medical journals, he plays a key role in maintaining the integrity and quality of scientific publications.

Research Interests

Dr. Amini Mahabadi’s research interests primarily encompass reproductive biology, stem cell technology, and infertility treatments. His investigations have focused on germ cell differentiation from induced pluripotent stem cells, the impact of environmental factors on fertility, and novel therapeutic approaches for reproductive disorders. His work also extends to exploring the role of genetic polymorphisms in infertility and employing herbal medicine in reproductive health. Additionally, he has contributed to the study of regenerative therapies, emphasizing the potential of bioengineered tissues in treating reproductive dysfunctions.

Awards

Dr. Amini Mahabadi has been recognized for his outstanding contributions to reproductive science and medical research. He has received several accolades and nominations for his pioneering work in infertility treatments and stem cell research. His dedication to advancing scientific knowledge has earned him esteemed awards from Kashan University of Medical Sciences and other professional organizations. His research findings have not only been acknowledged nationally but have also gained international recognition, underscoring his influence in the global scientific community.

Selected Publications

Amini Mahabadi J, Karimian M, Aghighi F, et al. “Retinoic acid and 17β-estradiol improve male germ cell differentiation from mouse-induced pluripotent stem cells.” Andrologia, 2020. (Cited by 45 articles)

Enderami SE, Mansour RN, Hasanzadeh E, et al. “Applications of blood plasma derivatives for cutaneous wound healing: A mini-review of clinical studies.” Regenerative Therapy, 2024. (Cited by 30 articles)

Rabbani S, Moshkdanian G, Azadchehr M, et al. “Investigating the difference in the length of lower limbs in patients with patellofemoral pain syndrome.” Archives of Trauma Research, 2024. (Cited by 25 articles)

Yousefzadeh M, Amini Mahabadi J, Karimian M, Nikzad H. “Evaluation of Association between HTR2A and SLC18A Genes Polymorphisms with the Risk of Male Infertility.” International Archives of Health Sciences, 2024. (Cited by 20 articles)

Soleimani Z, Esalatmanesh K, Azadchehr M, et al. “Examining the Outcome of Patients with COVID-19 Receiving Vitamin D Supplement.” International Archives of Health Sciences, 2024. (Cited by 18 articles)

Kosari M, Khorvash F, Sayyah MK, et al. “The influence of propolis plus Hyoscyamus niger L. against COVID‐19: A phase II, multicenter, placebo‐controlled, randomized trial.” Phytotherapy Research, 2024. (Cited by 15 articles)

Amini Mahabadi J, Sabzalipoor H, Bafrani HH, et al. “Application of induced pluripotent stem cell and embryonic stem cell technology to the study of male infertility.” Journal of Cellular Physiology, 2018. (Cited by 12 articles)

Conclusion

Dr. Javad Amini Mahabadi is a highly esteemed researcher whose work in reproductive biology and stem cell research has had a profound impact on the field. His dedication to scientific discovery, coupled with his extensive academic experience, positions him as a leader in infertility research. Through his numerous high-impact publications, collaborations, and mentorship roles, he continues to advance medical knowledge and inspire the next generation of researchers. His unwavering commitment to innovation and excellence ensures that his contributions will have a lasting influence on reproductive health and medical science.